Fractyl Health, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Fractyl Health, Inc. (GUTS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-10
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.50M, a 39.83% increase year-over-year.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.53M, a 80.01% increase year-over-year.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.64M, a 35.00% decline year-over-year.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.78M, a 52.90% decline year-over-year.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $6.68M, a 53.67% decline from fiscal 2024.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $14.43M, a 235.80% increase from fiscal 2023.
- Fractyl Health, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $4.30M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.50M 10-Q · filed 2026-08-10 | $5.03M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $2.53M 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $6.68M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | $1.64M 10-Q · filed 2025-11-12 | $3.42M derived: sum of 2 quarters · filed 2026-08-10 | $4.83M derived: sum of 3 quarters · filed 2026-08-10 | |
| 2025-06-30 | $1.78M 10-Q · filed 2026-08-10 | $3.19M derived: sum of 2 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $1.41M 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | $14.43M 10-K · filed 2026-03-24 | |||
| 2024-09-30 | $2.52M 10-Q · filed 2025-11-12 | $6.31M derived: sum of 2 quarters · filed 2025-11-12 | $11.53M derived: sum of 3 quarters · filed 2025-11-12 | |
| 2024-06-30 | $3.79M 10-Q · filed 2025-11-12 | $9.01M derived: sum of 2 quarters · filed 2025-11-12 | ||
| 2024-03-31 | $5.22M 10-Q · filed 2025-11-12 | |||
| 2023-12-31 | $4.30M 10-K · filed 2025-03-03 | |||
| 2023-09-30 | $1.09M 10-Q · filed 2024-11-12 | $2.16M derived: sum of 2 quarters · filed 2024-11-12 | $3.02M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $1.07M 10-Q · filed 2024-11-12 | $1.93M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $857.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |